Epigenetics Market Size, Share & Trends Report

Epigenetics Market Size, Share & Trends Analysis Report By Technology, By Application (Oncology, Non-oncology), By Product (Reagents, Instruments, Enzyme, Kits, Services), And Segment Forecasts, 2018 - 2025

  • Published Date: Sep, 2018
  • Base Year for Estimate: 2017
  • Report ID: 978-1-68038-583-0
  • Format: Electronic (PDF)
  • Historical Data: 2014 - 2016
  • Number of Pages: 153

Market Segmentation

  • Epigenetics Market Product Outlook (Market Revenue in USD Million, 2014 - 2025)
    • Reagents
    • Kits
      • ChIP sequencing kit
      • Whole Genomic Amplification kit
      • Bisulfite Conversion kit
      • RNA sequencing kit
      • Others
    • Instruments
    • Enzymes
    • Services
  • Epigenetics Technology Outlook (Revenue, USD Million, 2014 - 2025)
    • DNA Methylation
    • Histone Methylation
    • Histone Acetylation
    • Large non - coding RNA
    • MicroRNA modification
    • Chromatin structures
  • Epigenetics Application Outlook (Revenue, USD Million, 2014 - 2025)
    • Oncology
      • Solid tumors
      • Liquid tumors
    • Non - oncology
      • Inflammatory diseases
      • Metabolic diseases
      • Infectious diseases
      • Cardiovascular diseases
      • Others
  • Epigenetics Market Regional Outlook (Revenue, USD Million, 2014 - 2025)
    • North America
      • U.S.
        • U.S. Product Outlook (Revenue, USD Million; 2014 - 2025)
          • Reagents
          • Kits
            • ChIP sequencing kit
            • Whole Genomic Amplification kit
            • Bisulfite Conversion kit
            • RNA sequencing kit
            • Others
          • Instruments
          • Enzymes
          • Services
        • U.S. Technology Outlook (Revenue, USD Million, 2014 - 2025)
          • DNA Methylation
          • Histone Methylation
          • Histone Acetylation
          • Large non - coding RNA
          • MicroRNA modification
          • Chromatin structures
        • U.S. Application Outlook (Revenue, USD Million, 2014 - 2025)
          • Oncology
            • Solid tumors
            • Liquid tumors
          • Non - oncology
            • Inflammatory diseases
            • Metabolic diseases
            • Infectious diseases
            • Cardiovascular diseases
            • Others
      • Canada
        • Canada Product Outlook (Revenue, USD Million; 2014 - 2025)
          • Reagents
          • Kits
            • ChIP sequencing kit
            • Whole Genomic Amplification kit
            • Bisulfite Conversion kit
            • RNA sequencing kit
            • Others
          • Instruments
          • Enzymes
          • Services
        • Canada Technology Outlook (Revenue, USD Million, 2014 - 2025)
          • DNA Methylation
          • Histone Methylation
          • Histone Acetylation
          • Large non - coding RNA
          • MicroRNA modification
          • Chromatin structures
        • Canada Application Outlook (Revenue, USD Million, 2014 - 2025)
          • Oncology
            • Solid tumors
            • Liquid tumors
          • Non - oncology
            • Inflammatory diseases
            • Metabolic diseases
            • Infectious diseases
            • Cardiovascular diseases
            • Others
    • Europe
      • UK
        • UK Product Outlook (Revenue, USD Million; 2014 - 2025)
          • Reagents
          • Kits
            • ChIP sequencing kit
            • Whole Genomic Amplification kit
            • Bisulfite Conversion kit
            • RNA sequencing kit
            • Others
          • Instruments
          • Enzymes
          • Services
        • UK Technology Outlook (Revenue, USD Million, 2014 - 2025)
          • DNA Methylation
          • Histone Methylation
          • Histone Acetylation
          • Large non - coding RNA
          • MicroRNA modification
          • Chromatin structures
        • UK Application Outlook (Revenue, USD Million, 2014 - 2025)
          • Oncology
            • Solid tumors
            • Liquid tumors
          • Non - oncology
            • Inflammatory diseases
            • Metabolic diseases
            • Infectious diseases
            • Cardiovascular diseases
            • Others
      • Germany
        • Germany Product Outlook (Revenue, USD Million; 2014 - 2025)
          • Reagents
          • Kits
            • ChIP sequencing kit
            • Whole Genomic Amplification kit
            • Bisulfite Conversion kit
            • RNA sequencing kit
            • Others
          • Instruments
          • Enzymes
          • Services
        • Germany Technology Outlook (Revenue, USD Million, 2014 - 2025)
          • DNA Methylation
          • Histone Methylation
          • Histone Acetylation
          • Large non - coding RNA
          • MicroRNA modification
          • Chromatin structures
        • Germany Application Outlook (Revenue, USD Million, 2014 - 2025)
          • Oncology
            • Solid tumors
            • Liquid tumors
          • Non - oncology
            • Inflammatory diseases
            • Metabolic diseases
            • Infectious diseases
            • Cardiovascular diseases
            • Others
    • Asia Pacific
      • Japan
        • Japan Product Outlook (Revenue, USD Million; 2014 - 2025)
          • Reagents
          • Kits
            • ChIP sequencing kit
            • Whole Genomic Amplification kit
            • Bisulfite Conversion kit
            • RNA sequencing kit
            • Others
          • Instruments
          • Enzymes
          • Services
        • Japan Technology Outlook (Revenue, USD Million, 2014 - 2025)
          • DNA Methylation
          • Histone Methylation
          • Histone Acetylation
          • Large non - coding RNA
          • MicroRNA modification
          • Chromatin structures
        • Japan Application Outlook (Revenue, USD Million, 2014 - 2025)
          • Oncology
            • Solid tumors
            • Liquid tumors
          • Non - oncology
            • Inflammatory diseases
            • Metabolic diseases
            • Infectious diseases
            • Cardiovascular diseases
            • Others
      • China
        • China Product Outlook (Revenue, USD Million; 2014 - 2025)
          • Reagents
          • Kits
            • ChIP sequencing kit
            • Whole Genomic Amplification kit
            • Bisulfite Conversion kit
            • RNA sequencing kit
            • Others
          • Instruments
          • Enzymes
          • Services
        • China Technology Outlook (Revenue, USD Million, 2014 - 2025)
          • DNA Methylation
          • Histone Methylation
          • Histone Acetylation
          • Large non - coding RNA
          • MicroRNA modification
          • Chromatin structures
        • China Application Outlook (Revenue, USD Million, 2014 - 2025)
          • Oncology
            • Solid tumors
            • Liquid tumors
          • Non - oncology
            • Inflammatory diseases
            • Metabolic diseases
            • Infectious diseases
            • Cardiovascular diseases
            • Others
      • India
        • India Product Outlook (Revenue, USD Million; 2014 - 2025)
          • Reagents
          • Kits
            • ChIP sequencing kit
            • Whole Genomic Amplification kit
            • Bisulfite Conversion kit
            • RNA sequencing kit
            • Others
          • Instruments
          • Enzymes
          • Services
        • India Technology Outlook (Revenue, USD Million, 2014 - 2025)
          • DNA Methylation
          • Histone Methylation
          • Histone Acetylation
          • Large non - coding RNA
          • MicroRNA modification
          • Chromatin structures
        • India Application Outlook (Revenue, USD Million, 2014 - 2025)
          • Oncology
            • Solid tumors
            • Liquid tumors
          • Non - oncology
            • Inflammatory diseases
            • Metabolic diseases
            • Infectious diseases
            • Cardiovascular diseases
            • Others
    • Latin America
      • Brazil
        • Brazil Product Outlook (Revenue, USD Million; 2014 - 2025)
          • Reagents
          • Kits
            • ChIP sequencing kit
            • Whole Genomic Amplification kit
            • Bisulfite Conversion kit
            • RNA sequencing kit
            • Others
          • Instruments
          • Enzymes
          • Services
        • Brazil Technology Outlook (Revenue, USD Million, 2014 - 2025)
          • DNA Methylation
          • Histone Methylation
          • Histone Acetylation
          • Large non - coding RNA
          • MicroRNA modification
          • Chromatin structures
        • Brazil Application Outlook (Revenue, USD Million, 2014 - 2025)
          • Oncology
            • Solid tumors
            • Liquid tumors
          • Non - oncology
            • Inflammatory diseases
            • Metabolic diseases
            • Infectious diseases
            • Cardiovascular diseases
            • Others
      • Mexico
        • Mexico Product Outlook (Revenue, USD Million; 2014 - 2025)
          • Reagents
          • Kits
            • ChIP sequencing kit
            • Whole Genomic Amplification kit
            • Bisulfite Conversion kit
            • RNA sequencing kit
            • Others
          • Instruments
          • Enzymes
          • Services
        • Mexico Technology Outlook (Revenue, USD Million, 2014 - 2025)
          • DNA Methylation
          • Histone Methylation
          • Histone Acetylation
          • Large non - coding RNA
          • MicroRNA modification
          • Chromatin structures
        • Mexico Application Outlook (Revenue, USD Million, 2014 - 2025)
          • Oncology
            • Solid tumors
            • Liquid tumors
          • Non - oncology
            • Inflammatory diseases
            • Metabolic diseases
            • Infectious diseases
            • Cardiovascular diseases
            • Others
    • MEA
      • South Africa
        • South Africa Product Outlook (Revenue, USD Million; 2014 - 2025)
          • Reagents
          • Kits
            • ChIP sequencing kit
            • Whole Genomic Amplification kit
            • Bisulfite Conversion kit
            • RNA sequencing kit
            • Others
          • Instruments
          • Enzymes
          • Services
        • South Africa Technology Outlook (Revenue, USD Million, 2014 - 2025)
          • DNA Methylation
          • Histone Methylation
          • Histone Acetylation
          • Large non - coding RNA
          • MicroRNA modification
          • Chromatin structures
        • South Africa Application Outlook (Revenue, USD Million, 2014 - 2025)
          • Oncology
            • Solid tumors
            • Liquid tumors
          • Non - oncology
            • Inflammatory diseases
            • Metabolic diseases
            • Infectious diseases
            • Cardiovascular diseases
            • Others

Report content

Qualitative Analysis

  • Industry overview
  • Industry trends
  • Market drivers and restraints
  • Market size
  • Growth prospects
  • Porter’s analysis
  • PESTEL analysis
  • Key market opportunities prioritized
  • Competitive landscape
    • Company overview
    • Financial performance
    • Product benchmarking
    • Latest strategic developments

Quantitative Analysis

  • Market size, estimates, and forecast from 2014 to 2025
  • Market estimates and forecast for product segments up to 2025
  • Regional market size and forecast for product segments up to 2025
  • Market estimates and forecast for application segments up to 2025
  • Regional market size and forecast for application segments up to 2025
  • Company financial performance
What questions do you have? Get quick response from our industry experts. Request a Free Consultation
gvr icn

GET A FREE SAMPLE

gvr icn

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself...

gvr icn

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

BBB icon D&B icon

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure.